Amlodistad: Uses, Dosage & Side Effects
A calcium channel blocker (dihydropyridine) used to treat high blood pressure (hypertension) and chest pain from angina pectoris, including Prinzmetal’s variant angina
Amlodistad contains the active substance amlodipine, a dihydropyridine calcium channel blocker used to treat high blood pressure (hypertension) and angina pectoris (chest pain caused by reduced blood flow to the heart). Amlodipine is one of the most widely prescribed antihypertensive medications worldwide and is included on the WHO Model List of Essential Medicines. It works by relaxing blood vessel walls, allowing blood to flow more easily and reducing the workload on the heart. Amlodistad is taken once daily as a tablet, and its long duration of action provides smooth, consistent blood pressure control over a full 24-hour period.
Quick Facts: Amlodistad
Key Takeaways
- Amlodistad (amlodipine) is a calcium channel blocker that lowers blood pressure by relaxing the walls of blood vessels, reducing the resistance against which the heart must pump.
- It is used to treat hypertension (high blood pressure) and angina pectoris (chest pain), including the rare Prinzmetal’s (vasospastic) variant, and is taken as a once-daily tablet.
- The most common side effect is peripheral edema (swelling of the ankles or feet); other common effects include headache, dizziness, flushing, and fatigue, most of which are mild and transient.
- Amlodistad should not be used by patients with severe hypotension, hemodynamically significant aortic stenosis, cardiogenic shock, or unstable heart failure following a heart attack.
- Avoid grapefruit and grapefruit juice while taking Amlodistad, as they can unpredictably increase blood levels of the medication and cause an excessive drop in blood pressure.
What Is Amlodistad and What Is It Used For?
Amlodistad contains the active substance amlodipine, which belongs to a class of medicines called calcium channel blockers (also known as calcium antagonists). More specifically, amlodipine is a dihydropyridine-type calcium channel blocker, meaning it acts primarily on vascular smooth muscle rather than directly on the heart’s electrical system. This pharmacological profile gives amlodipine a favorable safety and efficacy balance that has made it one of the most commonly prescribed cardiovascular medicines in the world.
Amlodipine works by inhibiting the influx of calcium ions through L-type voltage-gated calcium channels in the cell membranes of vascular smooth muscle and, to a lesser extent, cardiac muscle. Calcium ions are essential for muscle contraction: when they enter smooth muscle cells in blood vessel walls, the vessel constricts and blood pressure rises. By blocking calcium entry, amlodipine causes the smooth muscle to relax, which widens (dilates) the peripheral arterioles. This reduction in peripheral vascular resistance directly lowers blood pressure. The effect is gradual and sustained, providing smooth blood pressure control over a full 24-hour dosing period without the abrupt hemodynamic changes that can occur with shorter-acting agents.
Amlodistad is prescribed for two primary conditions:
- High blood pressure (hypertension): Hypertension is a chronic condition in which the force of blood against the artery walls is consistently too high. Over time, uncontrolled high blood pressure damages blood vessels and vital organs, significantly increasing the risk of heart attack, stroke, heart failure, kidney disease, and vascular dementia. Amlodipine lowers blood pressure by reducing the resistance in the blood vessels, allowing the heart to pump blood more efficiently with less effort. The landmark ALLHAT trial and numerous meta-analyses have confirmed calcium channel blockers like amlodipine as first-line antihypertensive agents with proven cardiovascular protective benefits.
- Angina pectoris (chest pain): Angina occurs when the heart muscle does not receive enough oxygen-rich blood, typically because the coronary arteries are narrowed by atherosclerosis. Amlodipine helps angina in two ways: it reduces the heart’s oxygen demand by lowering blood pressure (afterload), and it improves coronary blood flow by directly dilating the coronary arteries. Amlodistad is effective for both stable (chronic) angina and Prinzmetal’s angina (also called vasospastic or variant angina), a rare form caused by coronary artery spasm rather than fixed atherosclerotic narrowing.
It is important to understand that Amlodistad is a preventive medication that works best when taken consistently every day. It does not provide immediate relief from an acute angina attack. For sudden chest pain episodes, fast-acting treatments such as sublingual nitroglycerin should be used as directed by your doctor. The full blood pressure-lowering effect of amlodipine develops gradually over 7 to 14 days, and steady-state blood levels are typically achieved after 7 to 8 days of consecutive daily dosing.
Amlodipine is listed on the World Health Organization (WHO) Model List of Essential Medicines, recognizing its importance in global healthcare. The European Society of Cardiology (ESC) and the American Heart Association (AHA) recommend calcium channel blockers, including amlodipine, as first-line treatment options for hypertension, particularly in elderly patients, patients of African descent, and patients with concomitant angina or Raynaud’s phenomenon.
Amlodipine is included on the WHO Model List of Essential Medicines, reflecting its proven safety, efficacy, and cost-effectiveness. It is recommended as a first-line treatment for hypertension by all major international cardiology guidelines, including those from the ESC/ESH (2023), AHA/ACC, and NICE.
What Should You Know Before Taking Amlodistad?
Before starting treatment with Amlodistad, it is essential that your doctor has a complete understanding of your medical history, current medications, and any allergies. This information helps ensure that amlodipine is safe and appropriate for you and that the correct dose is selected from the outset.
Contraindications
There are specific situations in which Amlodistad must not be used. Understanding these absolute contraindications is essential for your safety.
- Hypersensitivity: Do not take Amlodistad if you are allergic to amlodipine, amlodipine besylate, or any of the other ingredients in the tablet (listed in the contents section), or if you have had an allergic reaction to any other dihydropyridine calcium channel blocker. Symptoms of an allergic reaction may include itching, skin redness, rash, or difficulty breathing.
- Severe hypotension: If your blood pressure is already very low (severe hypotension), amlodipine could lower it further to dangerous levels, potentially causing fainting, dizziness, or organ damage.
- Hemodynamically significant aortic stenosis: In patients with a significantly narrowed aortic valve (aortic stenosis), the heart relies on maintaining blood pressure to ensure adequate circulation. Lowering blood pressure with amlodipine in this situation could be hazardous.
- Cardiogenic shock: This is a life-threatening condition in which the heart is unable to pump enough blood to meet the body’s needs. Amlodipine is not appropriate in this setting.
- Unstable heart failure after myocardial infarction: If you have developed heart failure that has not yet stabilized following a heart attack, amlodipine should not be initiated, as it could worsen cardiac function in this acute phase.
Warnings and Precautions
Talk to your doctor or pharmacist before taking Amlodistad if any of the following apply to you:
- Recent myocardial infarction: If you have recently had a heart attack, your doctor will carefully evaluate whether amlodipine is appropriate and safe for you. The PRAISE and PRAISE-2 trials demonstrated the safety of amlodipine in patients with heart failure and reduced ejection fraction, but individual assessment remains important.
- Heart failure: While amlodipine is one of the few calcium channel blockers that has been shown to be safe in patients with heart failure (unlike verapamil and diltiazem), it should be used with caution, and your doctor will monitor you closely.
- Hypertensive crisis: If you experience a sudden, severe increase in blood pressure, amlodipine is not the appropriate treatment for this acute emergency. Seek immediate medical care.
- Liver disease: Amlodipine is extensively metabolized by the liver. If you have liver disease or impaired liver function, the elimination of amlodipine may be significantly slowed, leading to higher blood levels and a greater risk of side effects. Your doctor may start you on a lower dose and monitor you more carefully.
- Elderly patients: If you are older, your doctor may start you on a lower dose and increase it more gradually, as elderly patients may be more sensitive to the blood pressure-lowering effects of amlodipine and more prone to certain side effects such as peripheral edema.
Children and Adolescents
Amlodipine has not been studied in children under 6 years of age. In children and adolescents aged 6 to 17 years, Amlodistad may be used for the treatment of hypertension only. It should not be used for angina in this age group. The appropriate dosing for children and adolescents is discussed in the dosage section below. If you are considering treatment for a child, consult your pediatrician or pediatric cardiologist for guidance specific to your child’s needs.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, planning to become pregnant, or breastfeeding, consult your doctor or pharmacist before using Amlodistad.
Pregnancy: The safety of amlodipine during pregnancy has not been established in adequate human clinical studies. Animal reproductive studies have shown adverse effects at high doses. Amlodipine should not be used during pregnancy unless there is no safer alternative and the potential benefit to the mother clearly outweighs the potential risk to the fetus. Other antihypertensive medications with more established safety profiles in pregnancy (such as labetalol, nifedipine, or methyldopa) are generally preferred. If you discover you are pregnant while taking Amlodistad, do not stop the medication abruptly but contact your doctor as soon as possible to discuss a plan.
Breastfeeding: Amlodipine passes into breast milk in small amounts. While the exposure to the infant is likely to be very low, the potential effects on a breastfed baby have not been fully studied. If you are breastfeeding or planning to breastfeed, discuss with your doctor whether the benefits of continued treatment outweigh any potential risks to your child. Your doctor may recommend an alternative medication or monitor both you and your baby.
Driving and Operating Machinery
Amlodistad may occasionally affect your ability to drive or operate machinery. Side effects such as dizziness, drowsiness, headache, fatigue, or nausea can occur, particularly at the beginning of treatment or when the dose is increased. If you experience any of these symptoms, do not drive, cycle, or use tools or machines until you know how the medication affects you. The risk typically decreases as your body adjusts to the medication over the first few days to weeks.
Sodium Content
Amlodistad tablets contain less than 1 mmol (23 mg) of sodium per tablet, meaning they are essentially sodium-free. This is relevant for patients on sodium-restricted diets, such as those with heart failure or kidney disease.
How Does Amlodistad Interact with Other Drugs?
Amlodipine is primarily metabolized by the CYP3A4 enzyme system in the liver. Medications that inhibit or induce CYP3A4 can therefore alter amlodipine blood levels, potentially affecting both its efficacy and safety. In addition, because amlodipine lowers blood pressure, combining it with other blood pressure-lowering agents can result in additive or excessive hypotension. It is essential to tell your doctor about all medicines you are taking, including prescription drugs, over-the-counter medications, herbal products, and dietary supplements.
Major Interactions
| Interacting Drug | Effect | Clinical Significance |
|---|---|---|
| Ketoconazole, Itraconazole (strong CYP3A4 inhibitors) | Significantly increased amlodipine blood levels, greater risk of hypotension and side effects | Avoid combination if possible; if unavoidable, monitor blood pressure closely and consider dose reduction |
| Ritonavir, Indinavir, Nelfinavir (HIV protease inhibitors) | Increased amlodipine plasma levels via CYP3A4 inhibition | Use with caution; close monitoring of blood pressure and side effects required |
| Rifampicin (strong CYP3A4 inducer) | Decreased amlodipine blood levels, potentially reduced antihypertensive efficacy | Monitor blood pressure; dose adjustment may be needed during and after rifampicin treatment |
| Dantrolene (IV infusion) | Risk of serious cardiovascular events including ventricular fibrillation and cardiovascular collapse with hyperkalaemia | Avoid combination; potentially life-threatening interaction |
| Simvastatin | Amlodipine increases simvastatin exposure by approximately 77%, raising the risk of myopathy and rhabdomyolysis | Limit simvastatin dose to 20 mg daily when co-administered with amlodipine |
Other Notable Interactions
| Interacting Drug | Effect | Clinical Significance |
|---|---|---|
| Verapamil, Diltiazem (non-dihydropyridine calcium channel blockers) | Additive negative inotropic and blood pressure-lowering effects | Use with caution; monitor heart rate and blood pressure closely |
| Erythromycin, Clarithromycin (macrolide antibiotics) | Moderate CYP3A4 inhibition may increase amlodipine levels | Monitor for increased side effects during antibiotic course |
| Cyclosporine | Amlodipine may increase cyclosporine blood levels | Monitor cyclosporine levels; dose adjustment of cyclosporine may be needed |
| Tacrolimus | Amlodipine may increase tacrolimus blood levels | Monitor tacrolimus levels and adjust dose if necessary |
| Other antihypertensives (ACE inhibitors, ARBs, beta-blockers, diuretics) | Additive blood pressure-lowering effect | Often used intentionally in combination therapy; monitor blood pressure |
| Grapefruit juice | CYP3A4 inhibition in gut wall increases amlodipine absorption and blood levels | Avoid grapefruit and grapefruit juice; unpredictable increase in blood pressure-lowering effect |
| St. John’s Wort (Hypericum perforatum) | CYP3A4 induction may decrease amlodipine blood levels | May reduce antihypertensive efficacy; inform your doctor if taking this herbal supplement |
Amlodipine can safely be combined with many commonly used medications, including thiazide diuretics, ACE inhibitors, angiotensin II receptor blockers, beta-blockers, long-acting nitrates, sublingual nitroglycerin, non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics (other than macrolides), oral hypoglycemic agents, and proton pump inhibitors. However, always confirm all drug interactions with your prescribing physician or pharmacist, especially when starting, stopping, or changing any medication.
What Is the Correct Dosage of Amlodistad?
Always take Amlodistad exactly as your doctor has prescribed. If you are uncertain about your dose, consult your doctor or pharmacist. The goal of treatment is to achieve and maintain an optimal blood pressure or to control angina symptoms while minimizing side effects.
Adults
Adults – Hypertension and Angina
Starting dose: 5 mg once daily
Maximum dose: 10 mg once daily
Dose adjustment: Your doctor may increase the dose to 10 mg after 2–4 weeks if your blood pressure is not adequately controlled or angina symptoms persist. The 10 mg tablet is scored and can be divided into two equal halves if needed.
Administration: Swallow the tablet whole with a glass of water. You may take it before or after meals. Take it at the same time every day to maintain consistent blood levels.
Children and Adolescents (6–17 years)
Children – Hypertension Only
Starting dose: 2.5 mg once daily
Maximum dose: 5 mg once daily
Note: Amlodistad 5 mg tablets are not manufactured to be split into equal 2.5 mg doses. If a 2.5 mg dose is required, an alternative amlodipine formulation designed for splitting should be used. Discuss this with your doctor or pharmacist.
Elderly Patients
Elderly (≥65 years)
Starting dose: 5 mg once daily (the same as younger adults)
Dose titration: Increase cautiously based on individual response. Elderly patients may be more sensitive to the blood pressure-lowering effect and may experience more pronounced peripheral edema.
Note: No specific dose reduction is required solely based on age, but the dose increase interval should be longer in elderly patients to allow full assessment of the effect at each dose level.
Patients with Liver Impairment
Starting dose: The lowest available dose (2.5 mg if available, or 5 mg with careful monitoring)
Note: The liver is the primary site of amlodipine metabolism. Patients with liver disease have delayed clearance, resulting in higher and more prolonged blood levels. Your doctor will start at the lowest possible dose and titrate cautiously with careful blood pressure monitoring.
Patients with Kidney Impairment
Dose: Standard dosing (5–10 mg daily)
Note: Changes in amlodipine blood levels do not correlate with the degree of kidney impairment. Amlodipine is not removed by dialysis. No dose adjustment is necessary for patients with reduced kidney function.
Missed Dose
If you forget to take a dose of Amlodistad, simply skip the missed dose and take your next dose at the regular time. Do not take a double dose to make up for the one you missed. Because amlodipine has a very long half-life (35–50 hours), missing a single dose is unlikely to cause a sudden rise in blood pressure. However, try to take your medication consistently at the same time each day for the best results.
Overdose
If you take too many Amlodistad tablets, or if a child accidentally ingests the medication, seek immediate medical attention by calling your local emergency services or contacting a poison control center.
Taking too many tablets can cause your blood pressure to drop to dangerously low levels. Symptoms of overdose may include severe dizziness, lightheadedness, feeling faint or weak, or loss of consciousness. If blood pressure falls low enough, it can lead to circulatory shock, in which the skin becomes cold and clammy and consciousness may be lost. In severe cases, fluid accumulation in the lungs (pulmonary edema) may develop, which can cause significant breathing difficulties. This complication may be delayed, potentially appearing 24 to 48 hours after ingestion.
There is no specific antidote for amlodipine overdose. Treatment in a medical facility may include activated charcoal (if administered within 1–2 hours of ingestion), intravenous fluids to support blood pressure, vasopressors (medications to raise blood pressure), intravenous calcium gluconate, and supportive monitoring. Due to amlodipine’s long half-life, observation for an extended period may be necessary.
Stopping Treatment
Do not stop taking Amlodistad without first discussing it with your doctor. Your doctor will advise you on how long you need to take the medication. If you stop taking it prematurely, your blood pressure may rise again, and your risk of cardiovascular complications could return. If you have concerns about continuing treatment, or if you are experiencing side effects, talk to your doctor, who can adjust your dose or consider alternative medications.
What Are the Side Effects of Amlodistad?
Like all medicines, Amlodistad can cause side effects, although not everybody gets them. Most side effects are mild and tend to occur early in treatment, often improving as your body adjusts to the medication. However, some side effects can be serious and require immediate medical attention.
Go to a hospital emergency department immediately if you experience any of the following: sudden wheezing, chest pain, shortness of breath, or difficulty breathing; swelling of the eyelids, face, lips, tongue, or throat causing significant difficulty breathing; severe skin reactions including extensive rash, hives, redness over the entire body, severe itching, blistering, peeling skin, or inflamed mucous membranes (Stevens-Johnson syndrome, toxic epidermal necrolysis); symptoms of a heart attack or abnormal heart rhythm.
Very Common
May affect more than 1 in 10 people
- Edema (swelling, particularly of the ankles and feet, due to fluid retention)
Common
May affect up to 1 in 10 people
- Headache, dizziness, drowsiness (especially at the start of treatment)
- Palpitations (awareness of heartbeat), flushing (hot flushes)
- Abdominal pain, nausea
- Changes in bowel habits, diarrhea, constipation, indigestion
- Fatigue, weakness
- Visual disturbances, double vision
- Muscle cramps
- Swollen ankles
Uncommon
May affect up to 1 in 100 people
- Mood changes, anxiety, depression, insomnia
- Tremor, taste changes, fainting, weakness
- Numbness or tingling in hands and feet, reduced pain sensation
- Tinnitus (ringing in the ears)
- Low blood pressure
- Rhinitis (sneezing, runny nose), cough
- Dry mouth, vomiting
- Hair loss, increased sweating, itching, red spots on skin, skin discoloration
- Difficulty urinating, increased need to urinate at night, increased urination frequency
- Erectile dysfunction, breast enlargement in men
- Pain, feeling unwell
- Joint or muscle pain, back pain
- Weight gain or weight loss
Rare
May affect up to 1 in 1,000 people
- Confusion
Very Rare
May affect up to 1 in 10,000 people
- Decreased white blood cells (leukopenia), decreased platelets (thrombocytopenia) which may lead to easy bruising or bleeding
- Elevated blood sugar (hyperglycemia)
- Peripheral neuropathy (nerve disorder causing weakness, tingling, or numbness)
- Gingival hyperplasia (swelling of the gums)
- Abdominal swelling, gastritis
- Abnormal liver function, hepatitis (liver inflammation), jaundice (yellowing of the skin and eyes), elevated liver enzymes
- Increased muscle tone (hypertonia)
- Vasculitis (inflammation of blood vessels, sometimes with skin rash)
- Photosensitivity (increased sensitivity to sunlight)
- Extrapyramidal symptoms: rigidity, tremor, movement disorders
Not Known
Frequency cannot be estimated from available data
- Tremor, rigid posture, mask-like facial expression, slow movements, shuffling and unbalanced gait (Parkinsonism-like symptoms)
If you experience any side effects, including those not listed above, or if any side effect becomes severe or persists for more than a week, tell your doctor or pharmacist. You can also report suspected side effects to your national pharmacovigilance authority (e.g., the EMA in Europe, the FDA MedWatch program in the United States, or the MHRA Yellow Card Scheme in the United Kingdom) to help monitor the ongoing benefit-risk profile of amlodipine.
Swelling of the ankles and feet is the most frequently reported side effect of amlodipine and results from the vasodilatory action of the drug rather than fluid overload. It is dose-dependent and more common at 10 mg than at 5 mg. The edema is typically mild to moderate, cosmetic rather than harmful, and not associated with weight gain from heart failure. If ankle swelling is bothersome, your doctor may consider adding a low-dose ACE inhibitor or ARB, which can counteract this effect, or may adjust your treatment regimen.
How Should You Store Amlodistad?
Proper storage of your medication is essential to maintain its effectiveness and safety throughout the treatment period.
- Keep out of sight and reach of children: Store the medication in a safe location where children cannot access it. Accidental ingestion by a child can cause a dangerous drop in blood pressure.
- Expiry date: Do not use Amlodistad after the expiry date stated on the carton after “EXP.” The expiry date refers to the last day of that month.
- Light protection: Store in the original packaging to protect the tablets from light. Amlodipine besylate is light-sensitive and prolonged exposure may degrade the active substance.
- Temperature: No special temperature storage requirements are specified beyond normal room conditions. Avoid exposure to excessive heat or moisture.
- Disposal: Do not throw unused medications into wastewater or household waste. Return unused tablets to your pharmacy for safe disposal. These measures help protect the environment.
What Does Amlodistad Contain?
Active Substance
The active substance is amlodipine, present as amlodipine besylate (also known as amlodipine besilate). The besylate salt form was chosen because of its superior physicochemical properties, including good aqueous solubility and chemical stability, which contribute to consistent absorption and reliable blood levels after oral administration.
- Amlodistad 5 mg tablets: Each tablet contains 5 mg of amlodipine (as amlodipine besylate), equivalent to approximately 6.94 mg of amlodipine besylate.
- Amlodistad 10 mg tablets: Each tablet contains 10 mg of amlodipine (as amlodipine besylate), equivalent to approximately 13.87 mg of amlodipine besylate.
Inactive Ingredients (Excipients)
- Microcrystalline cellulose (E460) – tablet binder and filler
- Calcium hydrogen phosphate (E341) – diluent
- Sodium starch glycolate (Type A) – disintegrant to aid tablet dissolution
- Magnesium stearate (E470b) – lubricant for tablet manufacturing
Appearance and Package Sizes
Amlodistad 5 mg: White, round tablets. Available in blister packs of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 100, or 120 tablets, as well as unit-dose perforated blisters. Not all pack sizes may be marketed in all countries.
Amlodistad 10 mg: White, round tablets with a score line on one side. The tablet can be divided into two equal 5 mg doses. Available in the same blister pack sizes as the 5 mg tablets.
Manufacturer
Amlodistad is manufactured and marketed by STADA Arzneimittel AG, Stadastrasse 2–18, 61118 Bad Vilbel, Germany. Manufacturing is also carried out by STADA M&D SRL, Turda, Romania. The local representative for the Nordic region is STADA Nordic ApS, Herlev, Denmark.
Frequently Asked Questions About Amlodistad
Amlodistad (amlodipine) is a calcium channel blocker used to treat two main conditions: high blood pressure (hypertension) and chest pain caused by angina pectoris. For hypertension, it lowers blood pressure by relaxing and widening blood vessels, reducing the risk of heart attack, stroke, and kidney disease. For angina, it increases blood flow to the heart muscle and reduces the heart’s workload, preventing chest pain episodes. It is effective for both stable angina and the rare Prinzmetal’s (vasospastic) angina.
Amlodistad begins to lower blood pressure within a few hours of taking the first dose, but the full therapeutic effect develops gradually over 7 to 14 days of continuous daily use. This is because amlodipine has a long half-life (35–50 hours), meaning it takes about a week for steady-state blood levels to be reached. For angina, you may notice a reduction in chest pain episodes within the first 1 to 2 weeks. Do not expect immediate symptom relief – Amlodistad is a preventive medication, not a rescue treatment for acute chest pain.
While there is no absolute prohibition, alcohol can enhance the blood pressure-lowering effect of amlodipine, potentially leading to symptoms such as dizziness, lightheadedness, or fainting. If you choose to drink alcohol, do so in moderation, be aware of how it affects you, and avoid driving or operating machinery. Discuss your alcohol consumption with your doctor, who can provide personalized advice based on your overall cardiovascular health.
The ankle swelling (peripheral edema) caused by amlodipine is not due to heart failure or salt and water retention. Instead, it results from the drug’s vasodilatory effect: amlodipine dilates the small arteries (arterioles) more than the small veins (venules), creating a pressure imbalance that pushes fluid from capillaries into the surrounding tissue, particularly in gravity-dependent areas like the ankles and feet. The edema is dose-dependent – more common at 10 mg than 5 mg – and typically cosmetic rather than harmful. Adding an ACE inhibitor or ARB can help counteract this effect by also dilating the venules.
Yes, amlodipine is frequently prescribed in combination with other antihypertensive medications to achieve better blood pressure control. Common and well-established combinations include amlodipine with an ACE inhibitor (e.g., ramipril, lisinopril), an angiotensin receptor blocker (e.g., valsartan, losartan), a thiazide diuretic, or a beta-blocker. In fact, international guidelines recommend combination therapy for most patients with hypertension, as it improves efficacy while minimizing dose-related side effects of individual drugs. Your doctor will select the most appropriate combination based on your specific medical profile.
Yes, amlodipine is considered safe and effective in elderly patients and is specifically recommended by international guidelines (ESC/ESH 2023, AHA/ACC) as a first-line option for hypertension in older adults. However, elderly patients may be more sensitive to the blood pressure-lowering effect and may experience more peripheral edema. No specific dose reduction is required, but doctors typically titrate the dose more cautiously in elderly patients. The standard starting dose of 5 mg daily applies, with increases made gradually based on response and tolerability.
References
- European Medicines Agency (EMA). Amlodipine – Summary of Product Characteristics. Available from: EMA.
- Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 2023;41(12):1874–2071. doi:10.1097/HJH.0000000000003480.
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127–e248.
- ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–2997.
- Packer M, O’Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure (PRAISE). N Engl J Med. 1996;335(15):1107–1114.
- British National Formulary (BNF). Amlodipine. National Institute for Health and Care Excellence (NICE). Available from: BNF.
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List. Geneva: WHO; 2023.
- Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT-BPLA). Lancet. 2005;366(9489):895–906.
- Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study. JAMA. 2004;292(18):2217–2225.
- Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363(9426):2022–2031.
Editorial Team
This article was written and reviewed by the iMedic Medical Editorial Team, comprising licensed specialist physicians with expertise in cardiology, internal medicine, and clinical pharmacology.
Medical Content
iMedic Cardiology Editorial Team – specialist physicians in cardiology and internal medicine with clinical experience in hypertension management
Medical Review
iMedic Medical Review Board – independent panel verifying accuracy against ESC/ESH Guidelines, AHA/ACC Guidelines, BNF, and WHO recommendations
Pharmacology Review
iMedic Clinical Pharmacology Team – specialists in drug interactions, pharmacokinetics, and medication safety
Accessibility & SEO
iMedic Digital Health Team – ensuring WCAG 2.2 AAA compliance and optimal search visibility
All content follows the GRADE evidence framework and is reviewed according to international medical guidelines. iMedic receives no commercial funding from pharmaceutical companies.